Concepedia

Chiaki Ishii

CI

Statistics

Publications

3

Citations

1.4K

H-Index

3

Active since

1995

Affiliations

Daiichi-Sankyo (Japan)(Current)

Chiaki Ishii is an author at Daiichi-Sankyo (Japan) specializing in medicine, her2 inhibitors, and oncology.

Publications per year

1995–2018

3

Publications

3

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Yusuke Ogitani, Tetsuo Aida, Katsunobu Hagihara et al. · Clinical Cancer Research · 2016 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +13

A HER2-Targeting Antibody–Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model

Tomomi Nakayama Iwata, Chiaki Ishii, Saori Ishida et al. · Molecular Cancer Therapeutics · 2018 · 273 citations

Medicine, Oncology, Pharmacology +17

Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones

Takashi Takenouchi, Chiaki Ishii, Mie Sugawara et al. · Antimicrobial Agents and Chemotherapy · 1995 · 45 citations

Life Sciences, Microbiology, Molecular Genetics +17

1–3 of 3